APOA1 and atherosclerosis: In the periphery, ApoA1 is also reported to modulate intestinal homeostasis and microbiota composition, and ApoA1 deficiency-driven dysbiosis may contribute to inflammation or predispose to atherosclerosis development [47], which supports potentially different pathophysiological roles for plasma and CNS ApoA1 pools in AD dementia.